Can ovarian cancer be detected early?
Ovarian cancer is a common and fatal malignant tumor of the female reproductive system. Although the research on ovarian cancer has gradually deepened in recent years, its early detection is still very difficult. According to statistics, only about 20% of ovarian cancer patients can be diagnosed in the early stages. In its early stages, ovarian cancer is highly effective in treating ovarian cancer, with about 94% of patients surviving more than five years after diagnosis. However, because early-stage ovarian cancer often has no obvious symptoms, many patients are diagnosed at an advanced stage. Therefore, understanding the early detection methods of ovarian cancer is crucial to improving patient survival rates.
Early detection methods of ovarian cancer mainly include regular women's health examinations and paying attention to abnormal symptoms of the body. Regular pelvic exams help your doctor evaluate the condition of your ovaries and uterus. Although the pelvic examination has limited sensitivity in detecting early-stage ovarian tumors, it can still be used to rule out other gynecological conditions. In the meantime, women should discuss the frequency and need for health exams with their doctors so that appropriate screening and monitoring can be done.
Attention to symptoms is equally important. Although there are usually no obvious symptoms in the early stages of ovarian cancer, some nonspecific symptoms may indicate the presence of ovarian cancer. These symptoms include abdominal or pelvic pain, bloating, difficulty eating, and urinary symptoms such as urinary urgency and frequency. If these symptoms persist almost daily for more than a few weeks, women should seek medical attention promptly for professional evaluation and examination. It is worth noting that many times these symptoms may also be caused by other benign diseases, so medical identification is required.
Currently, research into screening tests for ovarian cancer continues, but an effective universal screening method has not yet been found. Currently, the most commonly used screening methods include transvaginal ultrasound (TVUS) and CA-125 blood tests. CA-125 is a protein whose levels are elevated in most ovarian cancer patients. Although it cannot be used to confirm the diagnosis alone, it can improve the accuracy of diagnosis when combined with imaging tests. However, it is important to stress that these tests are not suitable for all women, especially those without risk factors or symptoms.
In short, early detection of ovarian cancer is an important step in improving the survival rate of patients. Although there is currently no perfect screening program, regular health examinations, paying close attention to physical symptoms, and timely medical treatment can effectively improve the chance of early diagnosis.
(Click to view an introduction to drugs for the treatment of ovarian cancer)
References:
https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging/detection.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)